Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis.
Ontology highlight
ABSTRACT: Influenza-associated pulmonary aspergillosis (IAPA) has been reported increasingly since the advent of use of neuraminidase (NA) inhibitors following the 2009 influenza pandemic. We hypothesize that blocking host NA modulates the immune response against Aspergillus fumigatus. We demonstrate that NA influences the host response against A. fumigatus in vitro and that oseltamivir increases the susceptibility of mice to pulmonary aspergillosis. Oseltamivir impairs the mouse splenocyte and human peripheral blood mononuclear cell (PBMC) killing capacity of A. fumigatus, and adding NA restores this defect in PBMCs. Furthermore, the sialic acid-binding receptor SIGLEC15 is upregulated in PBMCs stimulated with A. fumigatus. Silencing of SIGLEC15 decrease PB
SUBMITTER: Dewi IMW
PROVIDER: S-EPMC8149467 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
ACCESS DATA